Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
57.1%
% of PBE's 28 holdings also in BBP
30.8%
% of BBP's 55 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
PTC THERAPEUTICS INC | 2.8% | 2.1% | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 2.8% | 2.0% | 2.0% |
|
REGENERON PHARMACEUTICALS | 5.1% | 2.0% | 2.0% |
|
INTRA-CELLULAR THERAPIES INC | 2.9% | 2.0% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 5.3% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to BBP
|
BIO-TECHNE CORPORATION | 4.7% |
|
BIOMARIN PHARMACEUTICAL INC | 3.7% |
|
NEUROCRINE BIOSCIENCES INC | 3.4% |
|
GILEAD SCIENCES INC | 3.4% |
|
AMGEN INC | 3.2% |
|
CATALYST PHARMACEUTICAL PART | 3.2% |
|
BIOGEN IDEC INC | 3.2% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 3.1% |
|
REGENERON PHARMACEUTICALS | 3.0% |
PBE Underweight Relative to BBP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.6% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
ADMA BIOLOGICS, INC. | -2.5% |
|
SAREPTA THERAPEUTICS INC | -2.4% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% |
|
ASCENDIS PHARMA A/S | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |